temporal arteritis | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

8,458 results for “temporal arteritis”

undisclosed gene therapy (AAV, temporal lobe epilepsy)

ALS/FTD therapy（Expansion Therapeutics）

AMT-260

Tocilizumab(Actemra, RoActemra, Tyenne, Tofidence, Avtozma)

Conditions: Coronavirus Disease 2019 (COVID‑19), Cytokine Release Syndrome caused by CAR-T Cell Therapy +9 more

Rx

Investigational

Tempol

C₉H₁₈NO₂

Tocilizumab-bavi(TOFIDENCE)

Manufacturer: Organon (regulatory and commercial rights in the US), Bio-Thera Solutions Ltd. (product developer and manufacturer)

Conditions: Rheumatoid Arthritis, Giant Cell Arteritis +4 more

Arthritis(Belief BioMed)

Rheumatoid Arthritis (Antolrx)

Rheumatoid Arthritis (Precisionlife)

degenerative arthritis program

Page 1 of 5